GA
LLY icon

GSG Advisors’s Eli Lilly LLY Stock Holding History

GSG Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$475K Buy
516
+37
+8% +$37.5K 0.12% 77
2025
Q4 		$515K Sell
479
-91
-16% -$87K 0.13% 69
2025
Q3 		$470K Buy
570
+122
+27% +$90.8K 0.12% 74
2025
Q2 		$349K Buy
448
+33
+8% +$25.6K 0.1% 86
2025
Q1 		$313K Sell
415
-10
-2% -$8.32K 0.1% 87
2024
Q4 		$328K Buy
425
+13
+3% +$10.8K 0.1% 87
2024
Q3 		$364K Buy
412
+80
+24% +$71.9K 0.12% 84
2024
Q2 		$304K Sell
332
-8
-2% -$6.4K 0.11% 86
2024
Q1 		$264K Sell
340
-52
-13% -$37K 0.1% 88
2023
Q4 		$242K Buy
+392
New +$229K 0.09% 96

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GSG Advisors's LLY Position: Q1 2026 in Review

GSG Advisors increased its Eli Lilly (LLY) stake by 7.7% in Q1 2026, buying an estimated $37.5K and bringing the position to 516 shares worth $475K. The position accounts for 0.12% of the portfolio, ranked #77.

GSG Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $515K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GSG Advisors held 516 shares of Eli Lilly worth $475K as of Q1 2026.
  • GSG Advisors bought 37 Eli Lilly shares in Q1 2026, an estimated $37.5K.
  • Eli Lilly made up 0.12% of GSG Advisors's portfolio in Q1 2026, its #77 holding.
  • GSG Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • GSG Advisors's Eli Lilly position peaked at $515K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GSG Advisors's 13F filing for Q1 2026, filed 13 May 2026.